CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,049 | -73.7% | 213,644 | -42.5% | 0.01% | -84.5% |
Q4 2022 | $3,987 | -99.7% | 371,262 | +184.4% | 0.06% | +262.5% |
Q3 2022 | $1,222,000 | +5.6% | 130,521 | +3.0% | 0.02% | +14.3% |
Q2 2022 | $1,157,000 | +86.0% | 126,746 | +147.8% | 0.01% | +75.0% |
Q1 2022 | $622,000 | +81.3% | 51,155 | +81.5% | 0.01% | +100.0% |
Q4 2021 | $343,000 | +34.5% | 28,190 | +57.7% | 0.00% | +33.3% |
Q2 2021 | $255,000 | -77.4% | 17,877 | -65.6% | 0.00% | -81.2% |
Q1 2021 | $1,128,000 | +305.8% | 51,963 | +137.5% | 0.02% | +166.7% |
Q3 2020 | $278,000 | -1.4% | 21,880 | +32.8% | 0.01% | -14.3% |
Q2 2020 | $282,000 | -15.6% | 16,482 | -20.6% | 0.01% | +16.7% |
Q4 2019 | $334,000 | – | 20,755 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chescapmanager LLC | 1,655,576 | $4,685,280 | 0.73% |
Bain Capital Life Sciences Investors, LLC | 934,898 | $2,645,761 | 0.27% |
FNY Investment Advisers, LLC | 35,000 | $99 | 0.12% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,764,201 | $4,992,689 | 0.11% |
Ergoteles LLC | 358,275 | $1,013,918 | 0.05% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $239,220 | 0.04% |
PDT Partners, LLC | 85,088 | $240,799 | 0.03% |
PINNACLE ASSOCIATES LTD | 672,440 | $1,903,005 | 0.03% |
Alpine Global Management, LLC | 34,014 | $96,260 | 0.03% |
XTX Topco Ltd | 52,025 | $147,231 | 0.03% |